Karyopharm Therapeutics (KPTI) Other Non-Current Assets (2012 - 2026)
Karyopharm Therapeutics' Other Non-Current Assets came in at $318,000 for Q2 2026, down 9.1% from $350,000 a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Other Non-Current Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Karyopharm Therapeutics' Other Non-Current Assets was $351,000, down 73.7% from FY2024.
- Other Non-Current Assets carries a five-year compound annual growth rate of -13.4% (FY2020 to FY2025).
- Going back by year, Other Non-Current Assets was $1.33 million in FY2024 (+343.2%), $301,000 in FY2023 (-52.4%), $633,000 in FY2022 (-0.6%) and $637,000 in FY2021 (-11.8%).
- The Q2 2026 figure represents the lowest quarterly Other Non-Current Assets since Q3 2024.
- Year-over-year, Other Non-Current Assets increased in four of the last seven quarters, with growth averaging 132.9%.
- The fastest year-over-year change in Other Non-Current Assets over five years came in Q4 2024 (growth of 343.2%), and the weakest in Q4 2025 (a decline of 73.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Karyopharm Therapeutics | 12.16 Mn | -214.27 Mn | 32.35 Mn | 585,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 585,000.00 |
| Dec 31, 2025 | 618,000.00 |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 350,000.00 |
| Mar 31, 2025 | 1.67 Mn |
| Dec 31, 2024 | 1.67 Mn |
| Sep 30, 2024 | 306,000.00 |
| Jun 30, 2024 | 304,000.00 |
| Mar 31, 2024 | 304,000.00 |
| Dec 31, 2023 | 301,000.00 |
| Sep 30, 2023 | 381,000.00 |
| Jun 30, 2023 | 387,000.00 |
| Mar 31, 2023 | 634,000.00 |
| Dec 31, 2022 | 633,000.00 |
| Sep 30, 2022 | 626,000.00 |
| Jun 30, 2022 | 631,000.00 |
| Mar 31, 2022 | 636,000.00 |
| Dec 31, 2021 | 637,000.00 |
| Sep 30, 2021 | 639,000.00 |
| Jun 30, 2021 | 639,000.00 |
API Access
Karyopharm Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();